reference/9939029

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9939029

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, N.I.H., Extramural
endingPage	514
issn	1097-0142 0008-543X
issueIdentifier	3
pageRange	508-514
publicationName	Cancer
startingPage	508
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_266f09c09d1e3aa97cbfe9240f44f32b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fb63a4c71f6ec26e76dcd7358d3f722b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0d4fffafc8d662404048172fab252862 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8d174cd6a0b9731b1b13ec4cc5eede99 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f9db0a009848d3b9051dfed0bcbac227 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_39ca07b716b47e5050d334bdbe873d4d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b0152e1d33474694afd97fd114819802 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1c26e7a83451e70c4c51cf69de45473c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_288d3b52e1434f2c41383491a215da02 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2f2f58b4656d936311c1014b9af50e53 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2efad196d796aab7f3201956fbf1dada http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6915584dc615683d2882680b79106e61 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_636b440257b81fc76969778dea622a4e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6dbe111c1a657acb0ab52c9133cc7b6b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b88662a17e22ebcca1707e323327d3e8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e9081889dc95e89493a7ba161a76d7de http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bdedda6bc8f3d7b49612bce7a2d07095 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b4a49f0ceadae2893d5423046803eebe http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9cd0319ad1249191fac5eb3531c7ac94 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1e9758a7aec9cc3a5a00e9b5448cca4b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_14e450ec08b3cadc628e00bdc7aab72a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dba691968fc35a0e1b8833f688f8f07d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9d564233b9543dd351385e715fd6a9da http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3de99b234eaac1a6b312556d59ffa388 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3698541bf12ee6ead7e5f99c400906f5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4634c243785571d8327ee65dcc1b4370 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b52d36bbeb35469f69259f04186b2ff6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6c52b197315daecc8636d6b18ec3e128 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0adca88b0c729097db32c74c264ae68e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4909c7e27aa153ebe9ca6996b47341ed http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_844eab323994738a156684e6db96eb8d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d8b82a396e1c0f17b45729767fc2cc5e
bibliographicCitation	Ansell SM, Inwards DJ, Rowland KM, Flynn PJ, Morton RF, Moore DF, Kaufmann SH, Ghobrial I, Kurtin PJ, Maurer M, Allmer C, Witzig TE. Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group. Cancer. 2008 Aug 01;113(3):508–14. PMID: 18543327; PMCID: PMC3627208.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95d73f94f79c8f976d53034e4a92d30b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3155272d9f2ddac158d1067867f09d45 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ae9b14eecafd99c10e272ecb45023ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d28d14e9ce013c87c085d030ec406c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e348acc4664cedbb15de81ba694a15a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_893d972905384b2a9b47adffd881836c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ab7324b299e07de227c8e623fa40998 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1896d8dd6ce6f44ec7be33e4d382fc58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c870d51c92e9ac161853ed992c7a28a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4b226dace502a7cc9db3c885ed3d846 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6b2a21ab11147c07e1691719c7aa66a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f027149559f30b75730a992a4feac22a
date	2008-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/18543327 https://doi.org/10.1002/cncr.23580 https://pubmed.ncbi.nlm.nih.gov/PMC3627208
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771 https://portal.issn.org/resource/ISSN/0008-543X https://portal.issn.org/resource/ISSN/1097-0142
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group
discusses	http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0498543
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D020123Q000031 http://id.nlm.nih.gov/mesh/D020522Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D020522Q000401 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D020123Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D020123Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D004333
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137295275 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918289 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148191 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166639522 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145712265 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23375915 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122362113 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24847874 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361911 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361902 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361839 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361808 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163359784 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23308413 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129317846 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71433778 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23724530 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7078 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361806 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54608508 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361790 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361737 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361642 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361634 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18293306 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132274070 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168317584 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86287409 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86277830 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200276 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53486199 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168012331

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID244328266 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248184126 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214

Total number of triples: 129.